Protara Therapeutics Inc (TARA)

R&D Expenses

$16.96M

Quarterly · Period ending: · USD

TARA logo

TARA R&D Expenses

Latest reported$16.96M
TARA Quarterly R&D Expenses ($1.77M → $16.96M)
High-resolution chart · PNG

TARA r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Protara Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
16,955,000
13,472,000
13,124,000
9,591,000
10,770,000
9,148,000
9,499,000
8,070,000
6,387,000
7,665,000
6,381,000
6,218,000
7,247,000
5,143,000
4,989,000
3,466,000
3,084,000
5,269,000
4,068,000
4,093,000
5,887,000
7,040,000
3,651,273
2,796,000
2,469,720
3,065,000
-3,185,000
1,098,617
986,716
1,077,846
1,109,063
2,354,000
2,760,000
4,070,000
3,210,000
10,340,000
3,890,000
4,250,000
4,440,000
4,840,000
5,240,000
4,350,000
3,580,000
3,080,000
3,090,000
2,630,000
1,870,000
1,773,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.